NOS3 and cholestasis: However, since these two compounds have also been described as SP1 inhibitors [20] [21] with antioxidant properties [22] [23], and both, SP1 and oxidative stress, are related to NOS-3 expression regulation during cholestasis [12], these results could not be directly attributed to the inhibition of AP-1.